Environmental Research,
Journal Year:
2024,
Volume and Issue:
259, P. 119439 - 119439
Published: June 18, 2024
Increasing
amounts
of
wastewater
is
the
most
pervasive
and
challenging
environmental
problem
globally.
Conventional
treatment
methods
are
costly
entail
huge
energy
carbon
consumption
greenhouse
gas
emissions.
Owing
to
their
unique
ability
capturing
resource
recovery,
microalgae-microbiome
based
a
potential
approach
widely
used
for
carbon-neutral
treatment.
Microalgae-bacteria
synergy
(i.e.,
functionally
beneficial
microbial
synthetic
communities)
performs
better
enhances
carbon-sequestration
nutrient
recovery
from
plants.
This
review
presents
comprehensive
information
regarding
as
sustainable
agent
discusses
synergistic
approaches
effective
removal.
Moreover,
this
discusses,
role
omics-biology
Insilco
in
unravelling
understanding
algae-microbe
synergism
response
toward
Finally,
it
various
microbiome
engineering
developing
microalgae-bacteria
partners
sequestration
wastewater,
summarizes
future
research
perspectives
on
bioremediation.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: April 24, 2024
Achieving
cost-competitive
bio-based
processes
requires
development
of
stable
and
selective
biocatalysts.
Their
realization
through
in
vitro
enzyme
characterization
engineering
is
mostly
low
throughput
labor-intensive.
Therefore,
strategies
for
increasing
while
diminishing
manual
labor
are
gaining
momentum,
such
as
vivo
screening
evolution
campaigns.
Computational
tools
like
machine
learning
further
support
efforts
by
widening
the
explorable
design
space.
Here,
we
propose
an
integrated
solution
to
challenges
whereby
ML-guided,
automated
workflows
(including
library
generation,
implementation
hypermutation
systems,
adapted
laboratory
evolution,
growth-coupled
selection)
could
be
realized
accelerate
pipelines
towards
superior
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Oct. 3, 2023
Abstract
Microbial
production
of
succinic
acid
(SA)
at
an
industrially
relevant
scale
has
been
hindered
by
high
downstream
processing
costs
arising
from
neutral
pH
fermentation
for
over
three
decades.
Here,
we
metabolically
engineer
the
acid-tolerant
yeast
Issatchenkia
orientalis
SA
production,
attaining
highest
titers
in
sugar-based
media
low
(pH
3)
fed-batch
fermentations,
i.e.
109.5
g/L
minimal
medium
and
104.6
sugarcane
juice
medium.
We
further
perform
batch
using
a
pilot-scale
fermenter
(300×)
achieve
63.1
SA,
which
can
be
directly
crystallized
with
yield
64.0%.
Finally,
simulate
end-to-end
low-pH
pipeline,
techno-economic
analysis
life
cycle
assessment
indicate
our
process
is
financially
viable
reduce
greenhouse
gas
emissions
34–90%
relative
to
fossil-based
processes.
expect
I.
serve
as
general
industrial
platform
organic
acids.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: March 26, 2024
Abstract
To
broaden
the
substrate
scope
of
microbial
cell
factories
towards
renewable
substrates,
rational
genetic
interventions
are
often
combined
with
adaptive
laboratory
evolution
(ALE).
However,
comprehensive
studies
enabling
a
holistic
understanding
adaptation
processes
primed
by
metabolic
engineering
remain
scarce.
The
industrial
workhorse
Pseudomonas
putida
was
engineered
to
utilize
non-native
sugar
D-xylose,
but
its
assimilation
into
bacterial
biochemical
network
via
exogenous
xylose
isomerase
pathway
remained
unresolved.
Here,
we
elucidate
metabolism
and
establish
foundation
for
further
followed
ALE.
First,
native
glycolysis
is
derepressed
deleting
local
transcriptional
regulator
gene
hexR
.
We
then
enhance
pentose
phosphate
implanting
transketolase
transaldolase
two
lag-shortened
strains
allow
ALE
finetune
rewired
metabolism.
Subsequent
multilevel
analysis
reverse
provide
detailed
insights
parallel
paths
carbon
source,
highlighting
enhanced
expression
along
as
key
events
during
process.
Exploration,
Journal Year:
2024,
Volume and Issue:
4(6)
Published: March 28, 2024
Abstract
Because
therapeutic
cancer
vaccines
can,
in
theory,
eliminate
tumor
cells
specifically
with
relatively
low
toxicity,
they
have
long
been
considered
for
application
repressing
progression.
Traditional
containing
a
single
or
few
discrete
epitopes
failed
the
clinic,
possibly
due
to
challenges
epitope
selection,
target
downregulation,
cell
heterogeneity,
microenvironment
immunosuppression,
lack
of
vaccine
immunogenicity.
Whole
membrane
vaccines,
which
provide
rich
source
antigens,
are
emerging
as
viable
alternatives.
Autologous
and
allogenic
cellular
evaluated
clinical
treatments.
Tumor
membranes
(TCMs)
an
intriguing
antigen
source,
membrane‐accessible
targets
and,
at
same
time,
serve
integrated
carriers
adjuvants
other
agents.
This
review
provides
summary
properties
technologies
TCM
vaccines.
Characteristics,
categories,
mechanisms,
preparation
methods
discussed,
demonstrable
additional
benefits
derived
from
combining
chemotherapy,
sonodynamic
therapy,
phototherapy,
oncolytic
viruses.
Further
research
chemistry,
biomedicine,
immunology,
bioinformatics
address
current
drawbacks
could
facilitate
adoption
Trends in biotechnology,
Journal Year:
2024,
Volume and Issue:
42(11), P. 1339 - 1347
Published: May 28, 2024
Microbial
fermentations
offer
the
opportunity
to
produce
a
wide
range
of
chemicals
in
sustainable
fashion,
but
it
is
important
carefully
evaluate
production
costs.
This
can
be
done
on
basis
evaluation
titer,
rate,
and
yield
(TRY)
fermentation
process.
Here
we
describe
how
three
TRY
metrics
impact
technoeconomics
microbial
process,
illustrate
use
these
for
different
processes
two
commodity
chemicals,
1,3-propanediol
(PDO)
ethanol,
as
well
fine
chemical
penicillin.
On
our
discussions,
provide
some
recommendations
should
reported
when
new
are
described.
Current Opinion in Biotechnology,
Journal Year:
2024,
Volume and Issue:
85, P. 103061 - 103061
Published: Jan. 13, 2024
Bacterial
therapeutics
have
emerged
as
promising
delivery
systems
to
target
tumors.
These
engineered
live
can
be
harnessed
modulate
the
tumor
microenvironment
or
deliver
and
selectively
release
therapeutic
payloads
A
major
challenge
is
bacteria
systemically
without
causing
widespread
inflammation,
which
critical
for
many
tumors
that
are
not
accessible
direct
intratumoral
injection.
We
describe
potential
strategies
address
this
challenge,
along
with
approaches
specific
payload
biocontainment
ensure
safety.
will
pave
way
development
of
cost-effective,
widely
applicable
next-generation
cancer
therapeutics.
Biotechnology Journal,
Journal Year:
2024,
Volume and Issue:
19(2)
Published: Feb. 1, 2024
Abstract
CBG
(Cannabigerol),
a
nonpsychoactive
cannabinoid,
has
garnered
attention
due
to
its
extensive
antimicrobial
and
anti‐inflammatory
properties.
However,
the
natural
content
of
in
Cannabis
sativa
L.
is
minimal.
In
this
study,
we
developed
an
engineered
cell
factory
for
production
using
Saccharomyces
cerevisiae
.
We
introduced
CBGA
biosynthetic
pathway
into
S.
employed
several
strategies
enhance
production.
These
included
dynamically
inhibiting
competitive
bypass
key
metabolic
pathways
regulated
by
Erg20p.
Additionally,
implemented
dual
cytoplasmic‐peroxisomal
compartmentalization
approach
further
increase
Furthermore,
ensured
efficient
optimizing
NADPH
acetyl‐CoA
pools.
Ultimately,
our
strain
achieved
titer
138
mg
L
−1
through
fed‐batch
fermentation
5
bioreactor,
facilitated
microwave
decarboxylation
extraction.
findings
underscore
significant
potential
yeast
factories
achieving
higher
yields
cannabinoid
PLANT PHYSIOLOGY,
Journal Year:
2024,
Volume and Issue:
195(1), P. 36 - 47
Published: Jan. 2, 2024
Abstract
The
whole
field
of
synthetic
biology
(SynBio)
is
only
about
20
years
old,
and
plant
SynBio
younger
still.
Nevertheless,
within
that
short
time,
in
general
has
drawn
more
scientific,
philosophical,
government,
private-sector
interest
than
anything
since
the
recombinant
DNA
revolution.
Plant
SynBio,
particular,
now
drawing
relation
to
plants’
potential
help
solve
planetary
problems
such
as
carbon
capture
storage
replacing
fossil
fuels
feedstocks.
As
so
young
fast-developing,
we
felt
it
was
too
soon
try
analyze
its
history.
Instead,
set
out
essence
SynBio's
origins
early
development
through
interviews
with
8
field's
founders,
representing
5
countries
3
continents.
We
then
distilled
these
founders’
personal
recollections
reflections
into
this
review,
centering
narrative
on
timelines
for
pivotal
events,
articles,
funding
programs,
quoting
from
interviews.
have
archived
interview
recordings
documented
timeline
entries.
This
work
provides
a
resource
future
historical
scholarship.